Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin

Background. Direct-acting antiviral agents against HCV with or without peginterferon plus ribavirin result in higher eradication rates of HCV and shorter treatment duration. We examined which is better for predicting persistent virologic response, the assessment of serum HCV RNA at 12 or 24 weeks af...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Med Sci
Main Authors: Kanda, Tatsuo, Nakamoto, Shingo, Sasaki, Reina, Nakamura, Masato, Yasui, Shin, Haga, Yuki, Ogasawara, Sadahisa, Tawada, Akinobu, Arai, Makoto, Mikami, Shigeru, Imazeki, Fumio, Yokosuka, Osamu
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829545/
https://ncbi.nlm.nih.gov/pubmed/27076789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.14953
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados